SCHEMBL7147611

SCHEMBL7147611

Nc1nc(NCc2ccccc2)nc(-c2ccco2)c1F

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 13/20 0.58
ADORA1 P30542 13/20 0.58
ADORA2B P29275 12/20 0.58
ADORA3 P0DMS8 12/20 0.58
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
MEN1 O00255 1/20 0.52
POLB P06746 1/20 0.52
KMT2A Q03164 1/20 0.52
ATM Q13315 1/20 0.52
TMIGD3 P0DMS9 1/20 0.52
APP P05067 2/20 0.48
PDE5A O76074 1/20 0.46
NR1H4 Q96RI1 1/20 0.46
MAPT P10636 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7146154 0.86 ADORA2A (0.59) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL7145887 0.85 ADORA2A (0.58) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL7145971 0.85 ADORA2A (0.58) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL7147939 0.85 ADORA2A (0.58) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL7403612 0.81 PDE5A (0.51) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL7146723 0.80 MAPT (0.63) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL3683007 0.72 ADORA2A (0.74) ADORA2AADORA1ADORA2BADORA3KDM4E
SCHEMBL5161288 0.72 ADORA2A (0.77) ADORA2AADORA1ADORA2BADORA3TMIGD3
SCHEMBL7146937 0.71 PDE5A (0.51) ADORA2AADORA1ADORA2BADORA3TMIGD3
SCHEMBL7397486 0.71 PDE5A (0.51) ADORA2AADORA1ADORA2BADORA3APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed
US-20010027196-A1 Adenosine receptor ligands and their use in the treatment of disease F. HOFFMANN-LA ROCHE AG (CH) 2001-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010027196-A1 Adenosine receptor ligands and their use in the treatment of disease ADORA2A, ADORA2B, ADORA1 ADORA2A 1/4885ADORA1 3/4885ADORA2B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.